Nedap N.V. (LON:0NNU)

London flag London · Delayed Price · Currency is GBP · Price in EUR
86.00
-0.90 (-1.04%)
At close: Aug 1, 2025
-1.04%
Market Cap488.72M
Revenue (ttm)224.95M
Net Income (ttm)18.23M
Shares Outn/a
EPS (ttm)2.77
PE Ratio26.80
Forward PE23.36
Dividend2.74 (3.22%)
Ex-Dividend DateApr 23, 2025
Volume5
Average Volume214
Open87.80
Previous Close86.90
Day's Range86.00 - 87.80
52-Week Range52.60 - 87.80
Beta0.44
RSI73.06
Earnings DateJul 18, 2025

About Blueprint Medicines

Nedap N.V., together with its subsidiaries, develops and manufactures electronic equipment and software in the Netherlands, Germany, rest of Europe, North America, and internationally. The company offers software services, which support healthcare institutions in planning, registering, and administering care processes. Its healthcare software services include Nedap MediKIT, which simplifies workflow in general practices; Caren, a digital health platform; Nedap Luna that visually organizes the day to support individuals with cognitive challenges... [Read more]

Industry Hardware, Equipment & Parts
Sector Technology
Founded 1929
Employees 938
Stock Exchange London Stock Exchange
Ticker Symbol 0NNU
Full Company Profile

Financial Performance

In 2024, Nedap's revenue was 251.61 million, a decrease of -4.12% compared to the previous year's 262.43 million. Earnings were 18.53 million, a decrease of -14.39%.

Financial Statements

News

There is no news available yet.